Echocardiography in clinical practice: The burden of arterial hypertension. A multicenter Italian survey

Journal of Human Hypertension

Volumn 24, Issue 6, 2010, Pages 395-402

  Cuspidi, C ^a,b   Negri, F ^a,b   Giudici, V ^b   Capra, A ^a   Muiesan, M L ^c   Agabiti Rosei, E ^c   De Simone, G ^d   De Luca, N ^e   Tocci, G ^f   Morganti, A ^g  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d Department of Clinical and Experimental Medicine ^*  (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g Operative Unit of Endocrinology   (Italy)

Author keywords

Echocardiography; Hypertension; Left ventricular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY HEIGHT; BODY MASS; BODY SURFACE; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL PRACTICE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; OBESITY; OUTPATIENT DEPARTMENT; PRESCRIPTION; PREVALENCE; QUANTITATIVE ANALYSIS; SPHYGMOMANOMETRY; SYSTOLIC BLOOD PRESSURE; VALVULAR HEART DISEASE;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART VALVE DISEASES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; ITALY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; SMOKING;

EID: 77952429179     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.78     Document Type: Article

References (32)

1. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens 2008;21:500-508.
2. Schmieder RE. The role of non-haemodynamic factors in the genesis of LVH. Nephron Dial Transplant 2005;20:2610-2612.
3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-352.
4. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001;141:334-341.
5. Taylor HA, Penman AD, Han H, Dale-Michael A, Sketon TN, Fox ER et al. Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2007;99:1413-1420.
6. Koren MJ, Ulin RJ, Laragh JH, Devereux RB. Reduction of left ventricular mass during treatment of essential hypertension is associated with improved prognosis. Am J Hypertens 2002;15:1021-1028.
7. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004;292:2350-2356.
8. Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 2004;43:731-738.
9. Verdecchia P, Angeli F, Gattobigio R, Sardone M, Pede S, Reboldi GP. Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects. Am J Hypertens 2006;19:493-499.
10. de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH. Midwall left ventricular mechanics: an independent predictor of cardiovascular risk in hypertension. Circulation 1996;95:259-265. (Pubitemid 26031483)
11. Jennings GLR, McMullen JR. Left ventricular hypertrophy: beyond the image and defining the human cardiac phenotype in hypertension. J Hypertens 2007;25:941-947.
12. Di Tullio MR, Sacco RL, Sciacca RR, Homma S. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke 1999;30:2019-2024.
13. Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187.
14. Lavie CJ, Milani RV, Ventura HO, Messerli FH. Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction. Am J Cardiol 2006;98:1396-1399.
15. Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A, on behalf of the APROS Investigators. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey. J Hypertens 2002;20:1307-1314.
16. Schillaci G, de Simone G, Reboldi GP, Porcellati C, Devereux RB, Verdecchia P. Change in cardiovaascular risk profile by echocardiography in low- or mediumrisk hypertensives. J Hypertens 2002;20:1519-1525.
17. Martinez MA, Sancho T, Armada E, Rubio JM, Antón JL, Torre A et al. Prevalence of left ventricular hypertrophy in patients with mild hypertension in primary care: impact of echocardiography on cardiovascular risk stratification. Am J Hypertens 2003;16:556-563.
18. Cuspidi C, Meani S, Valerio C, Fusi V, Sala C, Zanchetti A. Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed hypertensives. J Hypertens 2006;24:1671-1677.
19. Martina B, Nordmann A, Dieterle T, Sigle JP, Bengel G, Kiefer G et al. Impact of baseline echocardiography on treatment outcome in primary care patients with newly detected arterial hypertension: a randomized trial. Am J Hypertens 2006;19:1150-1155.
20. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-618.
21. Zanchetti A, Cuspidi C, Comarella L, Agabiti-Rosei E, Ambrosioni E, Chiariello M et al. Left ventricular diastolic dysfunction in elderly hypertensives: results from the APROS-diadys Study. J Hypertens 2007;25:2158-2167.
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al., Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463.
23. Agabiti-Rosei E, de Simone G, Mureddu G, Trimarco B, Verdecchia P, Volpe M, Joint Committee of the Italian Society of Hypertension (SIIA), Italian Society of Cardiology (SIC), Associazione Nazionale Medici Cardiologici Ospedalieri (ANMCO). Arterial hypertension and cardiac damage. Diagnostic and therapeutic guidelines. High Blood Press Cardiovasc Prev 2008;3:141-170.
24. Cuspidi C, Valerio C, Sala C, Muiesan ML, Grandi AM, Palumbo G, et al., on behalf of the Lombardy Regional Section of the Italian Society of Hypertension. The Hyper-Pract Study: A multicentre survey on the accuracy of the echocardiographic assessment of hypertensive left ventricular hypertrophy in clinical practice. Blood Press 2008;17:124-128.
25. Devereux RB, Casale PN, Kligfield P, Eisemberg RR, Miller D, Campo E et al. Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. Am J Cardiol 1986;57:1388-1393.
26. Leibowitz D, Planer D, Ben-Ibgi F, Rott D, Weiss AT, Bursztyn M. Measurement of wall thickness alone does not accurately assess the presence of left ventricular hypertrophy. Clin Exp Hypertens 2007;29:119-125.
27. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kizman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly. The Cardiovascular Health Study. J Am Coll Cardiol 2001;37:1042-1048.
28. Alfakih K, Reid S, Hall A, Sivananthan MU. The assessment of left ventricular hypertrophy in hypertension. J Hypertens 2006;24:1223-1230.
29. Mancia G, Carugo S, Grassi G, Lanzarotti A, Schiavina S, Cesana G et al. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control. Data from the PAMELA population. Hypertension 2002;39:744-749.
30. Cuspidi C, Meani S, Valerio C, Sala C, Fusi V, Zanchetti A et al. Age and target organ damage in essential hypertension: role of the metabolic syndrome. Am J Hypertens 2007;20:296-303.
31. Coca A, Gabriel R, de la Figuera M, Lopez-Sendon JL, Fernandez R, Sagastagoitia JD et al. on behalf of the VITAE Investigators. The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension: the VITAE study. J Hypertens 1999;17:1471-1480.
32. de Simone G, Kizer JR, Chinali M, Roman MJ, Best LG, Lee ET et al. Normalization for body size and population-attributable risk of left ventricular hypertrophy. The Strong Heart Study. Am J Hypertens 2005;18:191-196. (Pubitemid 40332548)